John Aunins Email Address

Chief Marketing Officer

Seres Therapeutics, Inc. is a leading microbiome therapeutics platform company developing a novel class of biological drugs that are designed to treat disease by restoring the function of a dysbiotic microbiome, where the natural state of bacterial diversity and function is imbalanced. A Phase 2 study of Seres' program SER-109 has been completed in multiply recurrent Clostridium difficile infection. Seres' clinical candidate, SER-287, is being evaluated in a Phase 1b study in patients with mild-to-moderate ulcerative colitis (UC). Seres is also developing SER-262, the first ever synthetic microbiome therapeutic candidate, in a Phase 1b study in patients with primary CDI.

Career as an international sales, marketing, product management, business development, corporate development and operations executive for several leading enterprise software and hardware companies delivering solutions via licensing, hosted services, cloud computing, SaaS and BPO to Fortune 500 and Global 2000 firms, SMBs, as well as federal, state and local governments, in a variety of industries and geographies. Specialties include ERP, Supply Chain, B2B/B2C e-commerce, product information management, data exchange/ synchronization, AIDC, RFID, IoT, remote sensing, industrial automation, global sourcing, merchandise planning, demand forecasting, analytical CRM, customer loyalty, promotions management, price optimization, predictive analytics, machine learning, artificial intelligence, heuristics, cognitive computing, mobile commerce and mHealth Expertise: Profit and Loss (P&L) Responsibility Corporate Turnaround and Restructuring Field Operations and Sales Management Market Sensing and Financial Modeling New Product and Service Development Pricing, Licensing and Distribution Marketing Strategy and Program Execution Account-Based Marketing and Quantitative Marketing Digital Marketing and Social Selling Emerging Markets and Technologies International Expansion and Localization Commercialization and Monetization Mergers, Acquisitions and Joint Ventures Channels and Alliances Programs Customer Loyalty, Care and Retention Public, Analyst and Investor Relations